Answers are grounded in this paper and cite their sources.
Experiments demonstrate dual-activity inhibitors restore antibiotic effectiveness in Enterobacterales, suggesting new treatment options.
CCCP, FCCP and KCN exhibited inhibitory activity against VIM-1-like MBLs, restoring imipenem susceptibility in E. coli at very low concentrations (0.04-19.55 µM). Thus, certain efflux pump inhibitors, as well as the gaseous biological mediator cyanide, have a novel action as inhibitors of MBL enzymatic activity, which, in turn, renders them potentially useful as adjunct antibacterial agents.
No takes yet. Share an insight, caveat, or question.
Raro et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: